| 发明名称 |
METHODS FOR TREATING LIVER TRANSPLANT RECIPIENTS |
| 摘要 |
This application features interferon-free therapies for the prevention or treatment of HCV infection in liver transplant recipient. In one aspect, the treatment comprises administering a DAA combination to a liver transplant recipient after liver transplantation, wherein the DAA combination comprises Compound 1, ritonavir, Compound 2 and Compound 4. |
| 申请公布号 |
US2015174194(A1) |
申请公布日期 |
2015.06.25 |
| 申请号 |
US201414574654 |
申请日期 |
2014.12.18 |
| 申请人 |
AbbVie Inc. |
发明人 |
Bernstein Barry M.;Coakley Eoin;Vilchez Regis A. |
| 分类号 |
A61K38/07;A61K38/06;A61K31/513;A61K31/427 |
主分类号 |
A61K38/07 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A method of treatment for preventing or treating HCV infection in a liver transplant recipient, comprising administering a combination of DAAs to said recipient, wherein said treatment does not comprise the use of interferon, and said treatment last from 4 to 24 weeks. |
| 地址 |
North Chicago IL US |
